Blocknomi
Key Highlights Merck received FDA authorization for Lipfendra, marking the debut of an oral PCSK9 inhibitor for elevated cholesterol levels. Clinical studies demonstrated Lipfendra’s ability to decrease LDL cholesterol by…
Related articles
-
Why Did Crypto Betting Grow During the 2026 World Cup?
Crypto Daily Published 10.07.2026 10:16
-
XRP Take-Profit Targets All the Way to $7
The Crypto Basic Published 08.07.2026 08:27
-
Bitcoin Suisse lands Abu Dhabi license to unlock UAE crypto expansion
Crypto.News Published 07.07.2026 20:13
-
Bitpay Wins MiCA Approval as Europe Builds a Unified Crypto Payment Market
Bitcoin.com Published 16.07.2026 22:40
-
Middle East Tensions Drive Oil Surge While Equities and Digital Assets Retreat
Blocknomi Published 08.07.2026 07:10
-
Avalanche (AVAX) Price Forecast: What to Expect by 2031
Blocknomi Published 10.07.2026 08:43
-
Linux Foundation Backs XRP for AI Payments
U.Today Published 14.07.2026 15:22
-
Fidelity Leads Bitcoin ETF Inflows As Institutional Demand Shows Signs Of Life Again
NewsBTC Published 10.07.2026 13:50